Noevir Holdings Co., Ltd. (4928.T)
Kobe, JP
Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets such as Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics division focuses on developing and manufacturing skincare lines, featuring popular brands like Noevir and Nameraka Honpo. It also offers NOV hypoallergenic products and provides contract manufacturing services for cosmetic and quasi-drug formulations. Within its Pharmaceutical & Health Food segment, Noevir produces items such as Nanten Nodo Ame cough drops and functional beverages like Min Min Da Ha. This division also supplies a range of over-the-counter medications, including cold remedies, eye drops, and digestive aids, alongside various nutritional supplements. The "Other" segment broadens the company's scope through the sale and leasing of apparel and aircraft. Furthermore, the company is involved in manufacturing and selling toiletries, procuring and distributing makeup products and containers, and conducting market research. Its extensive aviation services encompass air transport, charter flight operations, ground handling, hanger rentals, and aircraft flight training, in addition to undertaking other aviation-related tasks. Noevir distributes its diverse product portfolio through multiple channels, including pharmacies, specialized retail outlets, general merchandise stores, supermarkets, e-commerce platforms, convenience stores, and a network of approximately 2,000 Noevir beauty studios and proprietary retail locations. Established in Tokyo, Japan, in 1964, Noevir Holdings Co., Ltd. maintains its headquarters there.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.64% | -4.54% | -6.03% | -8.68% | -6.86% | -9.46% | -1.17% | -23.18% | -14.95% | +34.94% | +286.59% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+1.4% Q1'26: -0.6% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+0.8% Q1'26: -16.2% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+9.3% Q1'26: +10.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+17.1% ★ Q1'26: +15.1% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+27.3% ★ Q1'26: +20.8% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.06× ★ Q1'26: 0.07× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2015 actual |
Sep 2016 actual |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
Sep 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
49.39B
est: 49.00B (+0.8%)
|
51.18B
est: 49.80B (+2.8%)
|
54.47B
est: 54.30B (+0.3%)
|
57.83B
est: 57.60B (+0.4%)
|
59.25B
est: 59.80B (-0.9%)
|
51.84B
est: 52.50B (-1.3%)
|
51.27B
est: 52.00B (-1.4%)
|
61.14B
est: 59.90B (+2.1%)
|
62.55B
est: 62.00B (+0.9%)
|
63.82B
est: 63.95B (-0.2%)
|
64.72B
est: 64.20B (+0.8%)
|
64.50B
64.50B – 64.50B
+0.5% YoY
|
65.80B
65.80B – 65.80B
+2.0% YoY
|
67.10B
67.10B – 67.10B
+2.0% YoY
|
| EBITDA |
8.87B
est: 9.41B (-5.8%)
|
9.52B
est: 9.56B (-0.5%)
|
11.88B
est: 10.43B (+13.9%)
|
13.24B
est: 11.06B (+19.7%)
|
13.81B
est: 11.49B (+20.2%)
|
9.76B
est: 10.08B (-3.2%)
|
10.05B
est: 9.99B (+0.6%)
|
11.57B
est: 11.50B (+0.5%)
|
12.24B
est: 11.91B (+2.8%)
|
12.44B
est: 12.28B (+1.2%)
|
11.94B
est: 12.33B (-3.1%)
|
12.39B
12.39B – 12.39B
+0.5% YoY
|
12.64B
12.64B – 12.64B
+2.0% YoY
|
12.89B
12.89B – 12.89B
+2.0% YoY
|
| EBIT |
7.59B
est: 8.42B (-9.8%)
|
7.82B
est: 8.55B (-8.6%)
|
9.99B
est: 9.33B (+7.1%)
|
11.35B
est: 9.89B (+14.7%)
|
12.00B
est: 10.27B (+16.8%)
|
8.06B
est: 9.02B (-10.6%)
|
8.56B
est: 8.93B (-4.1%)
|
10.12B
est: 10.29B (-1.7%)
|
11.03B
est: 10.65B (+3.6%)
|
11.42B
est: 11.65B (-1.9%)
|
11.08B
est: 11.69B (-5.2%)
|
11.75B
11.75B – 11.75B
+0.5% YoY
|
11.98B
11.98B – 11.98B
+2.0% YoY
|
12.22B
12.22B – 12.22B
+2.0% YoY
|
| Net Income |
4.89B
est: 4.40B (+11.1%)
|
5.05B
est: 4.50B (+12.2%)
|
7.08B
|
7.84B
est: 7.60B (+3.2%)
|
7.23B
est: 8.30B (-12.9%)
|
5.62B
est: 6.05B (-7.1%)
|
6.38B
est: 6.33B (+0.9%)
|
7.59B
est: 7.00B (+8.4%)
|
7.67B
est: 7.85B (-2.2%)
|
7.97B
est: 8.00B (-0.4%)
|
8.03B
est: 8.22B (-2.3%)
|
8.20B
8.20B – 8.20B
-0.2% YoY
|
7.95B
7.95B – 7.95B
-3.0% YoY
|
8.15B
8.15B – 8.15B
+2.5% YoY
|
| SGA |
23.24B
est: 20.88B (+11.3%)
|
23.42B
est: 21.22B (+10.3%)
|
23.47B
est: 23.14B (+1.4%)
|
23.64B
est: 24.55B (-3.7%)
|
23.90B
est: 25.48B (-6.2%)
|
22.83B
est: 22.37B (+2.0%)
|
22.44B
est: 22.16B (+1.3%)
|
31.98B
est: 25.53B (+25.3%)
|
31.54B
est: 26.42B (+19.4%)
|
31.73B
est: 27.25B (+16.4%)
|
10.91B
est: 27.36B (-60.1%)
|
27.49B
27.49B – 27.49B
+0.5% YoY
|
28.04B
28.04B – 28.04B
+2.0% YoY
|
28.59B
28.59B – 28.59B
+2.0% YoY
|
| EPS |
136.79
est: 128.90 (+6.1%)
|
142.44
est: 131.70 (+8.2%)
|
199.64
|
228.55
est: 222.50 (+2.7%)
|
211.56
est: 243.00 (-12.9%)
|
164.48
est: 177.10 (-7.1%)
|
186.88
est: 185.30 (+0.9%)
|
222.18
est: 204.90 (+8.4%)
|
224.64
est: 229.80 (-2.2%)
|
233.34
est: 234.20 (-0.4%)
|
235.10
est: 240.70 (-2.3%)
|
240.10
240.10 – 240.10
-0.2% YoY
|
232.80
232.80 – 232.80
-3.0% YoY
|
238.60
238.60 – 238.60
+2.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.14% | 535.8K | 0.58% |
| 2 | WisdomTree International High Dividend Fund DTH | 0.06% | 382.1K | 0.58% |
| 3 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.06% | 236.9K | 0.48% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.05% | 513.7K | 0.58% |
| 5 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.04% | 204.3K | 0.58% |
| 6 | iShares MSCI Japan Small-Cap ETF SCJ | 0.03% | 67.5K | 0.50% |
| 7 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 1.04M | 0.06% |
| 8 | iShares $ Treasury Bond 3-7yr UCITS ETF CBUG.DE | 0.02% | 77.9K | 0.10% |
| 9 | Avantis International Small Cap Equity ETF AVDS | 0.02% | 53.3K | 0.30% |
| 10 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 112.3K | 0.40% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Takashi Okura | Chief Executive Officer, President & Director | 516M | male |
| Kazuya Ayukawa | Executive Officer of Corporate Planning, Public Relations/IR Department & Chief Responsible Officer | — | — |
| Makoto Hashimoto | Executive Officer of Human Resources Department & Chief Responsible Officer | — | — |
| Ikkou Yoshida | VP & Representative Director | — | male |
| Takeshi Okura | MD & Director | — | male |
| Tatsuyuki Tanaka | Executive Officer of General Affairs & Legal Department and Chief Responsible Officer | — | — |
| Mitsuyoshi Hanyu | Executive Officer & Accounting Manager | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4928.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
